Varicose Vein Treatment Guidelines

Introduction to Varicose Vein Treatment

The American Family Physician recommends interventional therapy for patients with bilateral lower extremity varicose veins, chronic venous insufficiency, and failed conservative management 1

Patients must have documented reflux on duplex ultrasound to be considered for interventional therapy, as recommended by the American Family Physician 1, 3
Failed conservative management is a requirement for interventional therapy, with a documented trial of conservative therapy before proceeding to intervention 2, 3
Symptomatic presentation, such as pain, is a necessary criterion for interventional therapy, as it represents lifestyle-limiting symptoms that interfere with activities of daily living 2, 4

The American College of Radiology recommends endovenous thermal ablation as first-line treatment for symptomatic varicose veins with documented valvular reflux, with technical success rates of 91-100% at 1 year 1, 2, 3
Foam sclerotherapy is appropriate for tributary veins or smaller vessels, with occlusion rates of 72-89% at 1 year, as recommended by the American College of Phlebology 2, 3
Surgery is reserved for cases where endovenous techniques are not feasible, as recommended by the American Family Physician 1, 2

Reflux duration must be ≥500 milliseconds at saphenofemoral or saphenopopliteal junction for thermal ablation, as recommended by the American College of Phlebology 2, 3
Vein diameter must be ≥4.5mm for thermal ablation or ≥2.5mm for sclerotherapy, as recommended by the American College of Phlebology 2, 3, 4
Deep venous system patency must be verified to rule out deep venous thrombosis, as recommended by the American Family Physician 1, 3

The National Institute for Health and Care Excellence recommends offering external compression only if interventional treatment is ineffective, and as first-line therapy only in pregnant women 3
Endovenous thermal ablation need not be delayed for additional trials of external compression when symptoms are present and reflux is documented, as recommended by the American College of Phlebology 2
Treating saphenofemoral junction reflux first is essential before tributary sclerotherapy to prevent recurrence rates of 20-28% at 5 years, as recommended by the American College of Phlebology 2

High technical success rates of 91-100% occlusion at 1 year for thermal ablation can be expected, as reported by the American College of Phlebology 2, 3
Symptom improvement, including reduction in pain, heaviness, swelling, and improved quality of life, can be expected, as reported by the American College of Phlebology 2, 4
Potential complications include deep vein thrombosis, pulmonary embolism, nerve damage from thermal injury, and common sclerotherapy side effects, as reported by the American College of Phlebology 2, 3